Skip to content
2000
Volume 5, Issue 1
  • ISSN: 0250-6882
  • E-ISSN: 0250-6882
file format pdf download PDF
side by side viewer icon HTML

Abstract

Diagnosis and management of pulmonary hypertension (PH) in special populations, including pregnant women, patients requiring intensive care unit admission, and patients who develop complications such as ascites, pericardial effusion or develop COVID-19 infection, are very challenging.

PH is associated with poor outcomes in pregnant women as the haemodynamic changes during pregnancy greatly increase maternal mortality. If PH is suspected in pregnant women, further investigation using transthoracic echocardiography is essential, and confirmation with right heart catheterisation is required. All global guidelines recommend avoidance of pregnancy in patients diagnosed with PAH. However, if the patient becomes pregnant, the risks involved with the continuation of the pregnancy and termination of the pregnancy should be discussed.

Intensive care may be required in patients with PH for the management of comorbid conditions and following major surgeries and irrespective of the underlying cause of PH, haemodynamic compromise in these patients leads to right heart failure. The PH expert centre plays an important role in the critical care management of patients with PH. Patients with PH may also develop complications such as ascites and pericardial effusion; if not rapidly recognised and treated, these complications can lead to poor prognosis in affected patients.

This chapter aims to provide guidance to healthcare professionals in the clinical decision-making process for the diagnosis and management of PH in special populations.

© 2024 The Author(s). Published by Bentham Science Publisher.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/nemj/10.2174/0102506882333704240912062627
2024-01-01
2025-09-28

  • From This Site

    /content/journals/nemj/10.2174/0102506882333704240912062627
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/nemj/5/1/NEMJ-5-E02506882333704.html?itemId=/content/journals/nemj/10.2174/0102506882333704240912062627&mimeType=html&fmt=ahah

References

  1. ElkayamU. GolandS. PieperP.G. SilversidesC.K. High-Risk Cardiac Disease in Pregnancy.J. Am. Coll. Cardiol.201668550251610.1016/j.jacc.2016.05.05027443948
     [Google Scholar]
  2. PieperP.G. LameijerH. HoendermisE.S. Pregnancy and pulmonary hypertension.Best Pract. Res. Clin. Obstet. Gynaecol.201428457959110.1016/j.bpobgyn.2014.03.00324685319
     [Google Scholar]
  3. WeissB.M. ZempL. SeifertB. HessO.M. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996.J. Am. Coll. Cardiol.19983171650165710.1016/S0735‑1097(98)00162‑49626847
     [Google Scholar]
  4. BédardE. DimopoulosK. GatzoulisM.A. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?Eur. Heart J.200830325626510.1093/eurheartj/ehn59719147605
     [Google Scholar]
  5. GalièN. HumbertM. VachieryJ.L. GibbsS. LangI. TorbickiA. SimonneauG. PeacockA. Vonk NoordegraafA. BeghettiM. GhofraniA. Gomez SanchezM.A. HansmannG. KlepetkoW. LancellottiP. MatucciM. McDonaghT. PierardL.A. TrindadeP.T. ZompatoriM. HoeperM. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.Eur. Heart J.20163716711910.1093/eurheartj/ehv31726320113
     [Google Scholar]
  6. KhanJ. IdreesM. Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pregnancy in pulmonary hypertension.Ann. Thorac. Med.201495Suppl. 110810.4103/1817‑1737.13405025076988
     [Google Scholar]
  7. Chidananda SwamyM.N. MukherjeeA. RaoL. PandithS. Anaesthetic management of a patient with severe pulmonary arterial hypertension for renal transplantation.Indian J. Anaesth.201761216716910.4103/0019‑5049.19985428250487
     [Google Scholar]
  8. HumbertM. KovacsG. HoeperM.M. BadagliaccaR. BergerR.M.F. BridaM. CarlsenJ. CoatsA.J.S. Escribano-SubiasP. FerrariP. FerreiraD.S. GhofraniH.A. GiannakoulasG. KielyD.G. MayerE. MeszarosG. NagavciB. OlssonK.M. Pepke-ZabaJ. QuintJ.K. RådegranG. SimonneauG. SitbonO. ToniaT. ToshnerM. VachieryJ.L. Vonk NoordegraafA. DelcroixM. RosenkranzS. SchwerzmannM. Dinh-XuanA.T. BushA. AbdelhamidM. AboyansV. ArbustiniE. AsteggianoR. BarberàJ.A. BeghettiM. ČelutkienėJ. CikesM. CondliffeR. de ManF. FalkV. FauchierL. GaineS. GaliéN. Gin-SingW. GrantonJ. GrünigE. HassounP.M. HellemonsM. JaarsmaT. KjellströmB. KlokF.A. KonradiA. KoskinasK.C. KotechaD. LangI. LewisB.S. LinhartA. LipG.Y.H. LøchenM.L. MathioudakisA.G. MindhamR. MoledinaS. NaeijeR. NielsenJ.C. OlschewskiH. OpitzI. PetersenS.E. PrescottE. RakishevaA. ReisA. RistićA.D. RocheN. RodriguesR. Selton-SutyC. SouzaR. SwiftA.J. TouyzR.M. UlrichS. WilkinsM.R. WortS.J. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.Eur. Heart J.202243383618373110.1093/eurheartj/ehac23736017548
     [Google Scholar]
  9. de RaafM.A. BeekhuijzenM. GuignabertC. Vonk NoordegraafA. BogaardH.J. Endothelin-1 receptor antagonists in fetal development and pulmonary arterial hypertension.Reprod. Toxicol.201556455110.1016/j.reprotox.2015.06.04826111581
     [Google Scholar]
  10. DunnL. GreerR. FlenadyV. KumarS. Sildenafil in pregnancy: a systematic review of maternal tolerance and obstetric and perinatal outcomes.Fetal Diagn. Ther.2017412818810.1159/00045306227926905
     [Google Scholar]
  11. KampJ.C. von KaisenbergC. GreveS. WinterL. ParkD.H. FugeJ. KühnC. HoeperM.M. OlssonK.M. Pregnancy in pulmonary arterial hypertension: Midterm outcomes of mothers and offspring.J. Heart Lung Transplant.202140322923310.1016/j.healun.2020.12.00233376037
     [Google Scholar]
  12. Al-AzemM.A. Al-HazmiM. Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Intensive care management of pulmonary hypertension.Ann. Thorac. Med.201495Suppl. 112110.4103/1817‑1737.13405625076990
     [Google Scholar]
  13. HuynhTN WeigtSS SugarCA ShapiroS KleerupEC Prognostic factors and outcomes of patients with pulmonary hypertension admitted to the intensive care unit.J Crit Care201227739
     [Google Scholar]
  14. HoeperM.M. BenzaR.L. CorrisP. de PerrotM. FadelE. KeoghA.M. KühnC. SavaleL. KlepetkoW. Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension.Eur. Respir. J.2019531180190610.1183/13993003.01906‑201830545979
     [Google Scholar]
  15. SitbonO. JaïsX. SavaleL. CottinV. BergotE. MacariE.A. BouvaistH. DauphinC. PicardF. BulifonS. MontaniD. HumbertM. SimonneauG. Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study.Eur. Respir. J.20144361691169710.1183/09031936.0011631324627535
     [Google Scholar]
  16. KapurN.K. EspositoM.L. BaderY. MorineK.J. KiernanM.S. PhamD.T. BurkhoffD. Mechanical circulatory support devices for acute right ventricular failure.Circulation2017136331432610.1161/CIRCULATIONAHA.116.02529028716832
     [Google Scholar]
  17. BatalO. DardariZ. CostabileC. GorcsanJ. ArenaV.C. MathierM.A. Prognostic value of pericardial effusion on serial echocardiograms in pulmonary arterial hypertension.Echocardiography201532101471147610.1111/echo.1290925682779
     [Google Scholar]
  18. FenstadE.R. LeR.J. SinakL.J. Maradit-KremersH. AmmashN.M. AyalewA.M. VillarragaH.R. OhJ.K. FrantzR.P. McCullyR.B. McGoonM.D. KaneG.C. Pericardial effusions in pulmonary arterial hypertension: characteristics, prognosis, and role of drainage.Chest201314451530153810.1378/chest.12‑303323949692
     [Google Scholar]
  19. ShadrinI.Y. IdossaD. WalstonV. LeeJ.III IssaM. Pulmonary Hypertension and Pericardial Effusions—To Tap or Not to Tap.Am. J. Med.20201334e149e15010.1016/j.amjmed.2019.09.01631790659
     [Google Scholar]
  20. VallabhajosyulaS. KanuriS. SundaragiriP. AllaV. Management of Cardiac Tamponade in Severe Pulmonary Hypertension.Chest20141464881A10.1378/chest.1969231
     [Google Scholar]
  21. PlotnickG.D. RubinD.C. FelicianoZ. ZiskindA.A. Pulmonary hypertension decreases the predictive accuracy of echocardiographic clues for cardiac tamponade.Chest1995107491992410.1378/chest.107.4.9197705154
     [Google Scholar]
  22. RyanJ.J. The Impact of COVID-19 on Pulmonary HypertensionAmerican College of Cardiology2020
     [Google Scholar]
  23. MamzerA. WaligoraM. KopecG. Ptaszynska-KopczynskaK. KurzynaM. DarochaS. FlorczykM. MroczekE. Mularek-KubzdelaT. Smukowska-GoryniaA. WrotynskiM. ChrzanowskiL. Dzikowska-DiduchO. Perzanowska-BrzeszkiewiczK. PruszczykP. SkoczylasI. LewickaE. BlaszczakP. KarasekD. Kusmierczyk-DroszczB. Mizia-StecK. KaminskiK. JachecW. Peregud-PogorzelskaM. DoboszynskaA. GasiorZ. TomaszewskiM. PawlakA. ZablockaW. RyczekR. Widejko-PietkiewiczK. KasprzakJ.D. Impact of the COVID-19 pandemic on pulmonary hypertension patients: insights from the BNP-PL National database.Int. J. Environ. Res. Public Health20221914842310.3390/ijerph1914842335886278
     [Google Scholar]
  24. RyanJ.J. Melendres-GrovesL. ZamanianR.T. OudizR.J. ChakinalaM. RosenzweigE.B. Gomberg-MaitlandM. Care of patients with pulmonary arterial hypertension during the coronavirus (COVID‐19) pandemic.Pulm. Circ.20201021710.1177/204589402092015332426111
     [Google Scholar]
  25. SulicaR. CefaliF. MotschwillerC. FentonR. BarrosoA. StermanD. COVID-19 in pulmonary artery hypertension (PAH) patients: observations from a large PAH center in New York City.Diagnostics (Basel)202111112810.3390/diagnostics1101012833467533
     [Google Scholar]
  26. SeratiA. KeshmiriM.S. ShafaghiS. MohammadM.M. KashaniB.S. NaghashzadehF. MohamadifarA. ShafaghiM. NooraliS. HajimoradiM. AstaniB. AghdasiS. RiahiM. AlaviS. MalekR. MovahedM.R. The Outcome of Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the COVID-19 Pandemic.Crit. Pathw. Cardiol.2023222606410.1097/HPC.000000000000031737220659
     [Google Scholar]
  27. LeeJ.D. BurgerC.D. DelossantosG.B. GrinnanD. RalphD.D. RaynerS.G. RyanJ.J. SafdarZ. VentetuoloC.E. ZamanianR.T. LearyP.J. A survey-based estimate of COVID-19 incidence and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension and impact on the process of care.Ann. Am. Thorac. Soc.202017121576158210.1513/AnnalsATS.202005‑521OC32726561
     [Google Scholar]
/content/journals/nemj/10.2174/0102506882333704240912062627
Loading
Diagnosis and Management of PAH in Special Populations in the UAE
NEW Emirates Medical J 5, e02506882333704 (2024); https://doi.org/10.2174/0102506882333704240912062627
/content/journals/nemj/10.2174/0102506882333704240912062627
/content/journals/nemj/10.2174/0102506882333704240912062627
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Ascites; Covid-19; Intensive care; Pericardial effusion; Pregnancy; Pulmonary hypertension; Special population

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test